Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (551-560 of 749) with videos related to

Pageof 75
Sort By:
Vox Sanguinis|April 24, 2020
Operational protocol for donation of anti-COVID-19 convalescent plasma in ItalyMassimo Franchini, Giuseppe Marano, Claudio Velati, et al.
Leukemia Research|May 3, 2005
Analysis of HFE and TFR2 gene mutations in patients with acute leukemiaDino Veneri, Massimo Franchini, Mauro Krampera, et al.
Diagnosis (Berlin, Germany)|July 2, 2021
Superwarfarin poisoning: a challenging diagnosisMario Pezzo, Marica Orioli, Mauro Pagani, et al.
Transfusion|July 1, 2004
Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgeryMassimo Franchini, Giorgio Gandini, Dario Regis, et al.
American Journal of Hematology|May 9, 2006
High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebrand diseaseMassimo Franchini, Dino Veneri, Giovanni Poli, et al.
Haematologica|September 13, 2003
Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutationsDino Veneri, Massimo Franchini, Flavia Zanetti, et al.
Seminars in Thrombosis and Hemostasis|March 28, 2017
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the LiteratureFrancesco Dentali, Vera Gessi, Rossella Marcucci, et al.
Digestive Diseases and Sciences|May 14, 2003
Nonresponse to interferon monotherapy in HCV-related chronic hepatitis: results of retreatment and prognostic factorsFranco Capra, Elena De Maria, Massimo Franchini, et al.
Seminars in Thrombosis and Hemostasis|February 20, 2010
Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VIIMassimo Franchini, Franco Manzato, Gian Luca Salvagno, et al.
Journal of Thrombosis and Thrombolysis|September 6, 2007
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasmaGiuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, et al.
Pageof 75

Showing results (551-560 of 749) with videos related to

Sort By:
Pageof 75
Vox Sanguinis|April 24, 2020
Operational protocol for donation of anti-COVID-19 convalescent plasma in ItalyMassimo Franchini, Giuseppe Marano, Claudio Velati, et al.
Leukemia Research|May 3, 2005
Analysis of HFE and TFR2 gene mutations in patients with acute leukemiaDino Veneri, Massimo Franchini, Mauro Krampera, et al.
Diagnosis (Berlin, Germany)|July 2, 2021
Superwarfarin poisoning: a challenging diagnosisMario Pezzo, Marica Orioli, Mauro Pagani, et al.
Transfusion|July 1, 2004
Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgeryMassimo Franchini, Giorgio Gandini, Dario Regis, et al.
American Journal of Hematology|May 9, 2006
High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebrand diseaseMassimo Franchini, Dino Veneri, Giovanni Poli, et al.
Haematologica|September 13, 2003
Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutationsDino Veneri, Massimo Franchini, Flavia Zanetti, et al.
Seminars in Thrombosis and Hemostasis|March 28, 2017
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the LiteratureFrancesco Dentali, Vera Gessi, Rossella Marcucci, et al.
Digestive Diseases and Sciences|May 14, 2003
Nonresponse to interferon monotherapy in HCV-related chronic hepatitis: results of retreatment and prognostic factorsFranco Capra, Elena De Maria, Massimo Franchini, et al.
Seminars in Thrombosis and Hemostasis|February 20, 2010
Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VIIMassimo Franchini, Franco Manzato, Gian Luca Salvagno, et al.
Journal of Thrombosis and Thrombolysis|September 6, 2007
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasmaGiuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, et al.
Pageof 75